252 related articles for article (PubMed ID: 12911344)
1. A wound contraction experimental model for studying keloids and wound-healing modulators.
Kamamoto F; Paggiaro AO; Rodas A; Herson MR; Mathor MB; Ferreira MC
Artif Organs; 2003 Aug; 27(8):701-5. PubMed ID: 12911344
[TBL] [Abstract][Full Text] [Related]
2. SB-431542 inhibits TGF-beta-induced contraction of collagen gel by normal and keloid fibroblasts.
Hasegawa T; Nakao A; Sumiyoshi K; Tsuchihashi H; Ogawa H
J Dermatol Sci; 2005 Jul; 39(1):33-8. PubMed ID: 15978417
[TBL] [Abstract][Full Text] [Related]
3. Conditioned medium from keloid keratinocyte/keloid fibroblast coculture induces contraction of fibroblast-populated collagen lattices.
Mukhopadhyay A; Tan EK; Khoo YT; Chan SY; Lim IJ; Phan TT
Br J Dermatol; 2005 Apr; 152(4):639-45. PubMed ID: 15840092
[TBL] [Abstract][Full Text] [Related]
4. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
5. Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts.
Younai S; Nichter LS; Wellisz T; Reinisch J; Nimni ME; Tuan TL
Ann Plast Surg; 1994 Aug; 33(2):148-51. PubMed ID: 7979045
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human platelet-derived growth factor and transforming growth factor-beta mediated contraction of human dermal fibroblast populated lattices is inhibited by Rho/GTPase inhibitor but does not require phosphatidylinositol-3' kinase.
Han YP; Nien YD; Garner WL
Wound Repair Regen; 2002; 10(3):169-76. PubMed ID: 12100378
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta2 activates proliferative scar fibroblasts.
Smith P; Mosiello G; Deluca L; Ko F; Maggi S; Robson MC
J Surg Res; 1999 Apr; 82(2):319-23. PubMed ID: 10090846
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Human Decorin Inhibits TGF-b1 Induced Contraction of Collagen Lattice by Keloid Fibroblasts.
Zhang Z; Garron T; Li XJ; Liu Y; Zhang X; Li YY; Xu WS
Wounds; 2009 Feb; 21(2):47-56. PubMed ID: 25903025
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts.
Zhang Z; Garron TM; Li XJ; Liu Y; Zhang X; Li YY; Xu WS
Burns; 2009 Jun; 35(4):527-37. PubMed ID: 19167828
[TBL] [Abstract][Full Text] [Related]
11. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin-1 promotes fibroblast-mediated collagen gel contraction caused by activation of latent transforming growth factor beta-1.
Sakai K; Sumi Y; Muramatsu H; Hata K; Muramatsu T; Ueda M
J Dermatol Sci; 2003 Apr; 31(2):99-109. PubMed ID: 12670720
[TBL] [Abstract][Full Text] [Related]
13. Role of growth factors in scar contraction: an in vitro analysis.
Younai S; Venters G; Vu S; Nichter L; Nimni ME; Tuan TL
Ann Plast Surg; 1996 May; 36(5):495-501. PubMed ID: 8743660
[TBL] [Abstract][Full Text] [Related]
14. The role of the fetal fibroblast and transforming growth factor-beta in a model of human fetal wound repair.
Lin RY; Adzick NS
Semin Pediatr Surg; 1996 Aug; 5(3):165-74. PubMed ID: 8858763
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor (EGF) antagonizes transforming growth factor (TGF)-beta1-induced collagen lattice contraction by human skin fibroblasts.
Park JS; Kim JY; Cho JY; Kang JS; Yu YH
Biol Pharm Bull; 2000 Dec; 23(12):1517-20. PubMed ID: 11145189
[TBL] [Abstract][Full Text] [Related]
16. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
Wu CS; Wu PH; Fang AH; Lan CC
Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
[TBL] [Abstract][Full Text] [Related]
17. Heparin stimulates production of bFGF and TGF-beta 1 by human normal, keloid, and fetal dermal fibroblasts.
Carroll LA; Koch RJ
Med Sci Monit; 2003 Mar; 9(3):BR97-108. PubMed ID: 12640331
[TBL] [Abstract][Full Text] [Related]
18. Effects of collagen matrix containing transforming growth factor (TGF)-beta(1) on wound contraction.
Tateshita T; Ono I; Kaneko F
J Dermatol Sci; 2001 Oct; 27(2):104-13. PubMed ID: 11532374
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
Sato M
Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
[TBL] [Abstract][Full Text] [Related]
20. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.
Fujiwara M; Muragaki Y; Ooshima A
Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
